What one share of Precigen holds
We are a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients. We are leveraging our proprietary technology platforms to develop product candidates designed to target urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases.
Precigen’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.23 |
|---|---|
| Profit | −$0.42 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.31 |
| Cash and investments | $0.05 |
| Debt | $0.26 |
| Book value | $0.12 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $1.53 | −$18.92 | $2.48 | −$18.08 | — | −$42.22 |
| 2012 | $2.49 | −$18.77 | $1.35 | −$12.47 | — | −$56.80 |
| 2013 | $0.58 | −$1.40 | $0.04 | −$1.35 | — | — |
| 2014 | $0.73 | −$0.83 | $0.06 | −$0.26 | — | $3.83 |
| 2015 | $1.56 | −$0.76 | $0.11 | $0.21 | — | $5.95 |
| 2016 | $1.62 | −$1.58 | $0.27 | −$0.68 | — | $4.72 |
| 2017 | $1.92 | −$0.98 | $0.39 | −$1.25 | — | $4.37 |
| 2018 | $1.17 | −$3.93 | $0.32 | −$1.28 | — | $2.27 |
| 2019 | $0.59 | −$2.09 | $0.25 | −$1.13 | — | $0.44 |
| 2020 | $0.19 | −$1.02 | $0.05 | −$0.51 | — | $0.36 |
| 2021 | $0.07 | −$0.47 | $0.04 | −$0.32 | — | $0.52 |
| 2022 | $0.13 | $0.14 | $0.02 | −$0.35 | — | $0.61 |
| 2023 | $0.03 | −$0.39 | $0.01 | −$0.28 | — | $0.48 |
| 2024 | $0.01 | −$0.47 | $0.03 | −$0.29 | — | $0.13 |
| 2025 | $0.03 | −$1.37 | $0.01 | −$0.29 | — | $0.06 |
Common questions about Precigen
How much does one share of Precigen earn?
Over the last 12 months, Precigen lost $0.42 for each share on $0.23 of sales.
Does Precigen pay a dividend?
Precigen didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Precigen’s book value per share?
Precigen’s book value is $0.12 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Precigen have?
Each share of Precigen has $0.05 of cash and investments and $0.26 of debt, as of June 30, 2026.
What is Precigen’s free cash flow per share?
−$0.31 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Precigen bought back shares?
Precigen’s share count rose about 5872% from 2011 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.